We are live on ! Find out more
STML

Stemline Therapeutics, Inc.
STML

Delisted

STML was delisted on the 9th of June, 2020.

Back to rankings

0 hedge funds and large institutions have $0 invested in Stemline Therapeutics, Inc. in 2020 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 94 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 94 → 0 (-94)

100% less funds holding in top 10

Funds holding in top 10: 2 → 0 (-2)

100% less capital invested

Capital invested by funds: $194M → $0 (-$194M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 94

Holders
–
Holders Change
-94
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
94
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
EAM
Eventide Asset Management
Massachusetts
-$20.1M
2
BlackRock
BlackRock
New York
-$18.1M
3
RCMNY
Rubric Capital Management (New York)
New York
-$16.2M
4
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$14.9M
5
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance)
Ontario, Canada
-$12.5M
Name Holding Trade Value Shares
Change 		Change in
Stake
Renaissance Technologies
26
Renaissance Technologies
New York
– -$766K -158,213 Closed
CS
27
Candriam SCA
Luxembourg
– -$1.55M -149,466 Closed
N
28
Nuveen
North Carolina
– -$713K -147,252 Closed
CC
29
Carlson Capital
Texas
– -$621K -128,349 Closed
Victory Capital Management
30
Victory Capital Management
Texas
– -$616K -127,270 Closed
California Public Employees Retirement System
31
California Public Employees Retirement System
California
– -$494K -102,132 Closed
Ameriprise
32
Ameriprise
Minnesota
– -$479K -99,050 Closed
DMK
33
David M. Knott
– -$435K -89,864 Closed
Citadel Advisors
34
Citadel Advisors
Florida
– -$429K -88,520 Closed
Swiss National Bank
35
Swiss National Bank
Switzerland
– -$423K -87,400 Closed
Los Angeles Capital Management
36
Los Angeles Capital Management
California
– -$415K -85,805 Closed
WMSA
37
Weiss Multi-Strategy Advisers
New York
– -$396K -81,770 Closed
State of Wisconsin Investment Board
38
State of Wisconsin Investment Board
Wisconsin
– -$382K -78,900 Closed
CS
39
Credit Suisse
Switzerland
– -$353K -73,061 Closed
AllianceBernstein
40
AllianceBernstein
Tennessee
– -$346K -71,500 Closed
California State Teachers Retirement System (CalSTRS)
41
California State Teachers Retirement System (CalSTRS)
California
– -$342K -70,661 Closed
Susquehanna International Group
42
Susquehanna International Group
Pennsylvania
– -$286K -59,168 Closed
VEA
43
Virtus ETF Advisers
New York
– -$283K -58,544 Closed
RhumbLine Advisers
44
RhumbLine Advisers
Massachusetts
– -$273K -56,322 Closed
Allianz Asset Management
45
Allianz Asset Management
Germany
– -$256K -52,863 Closed
VFA
46
Values First Advisors
Tennessee
– -$252K -52,012 Closed
Russell Investments Group
47
Russell Investments Group
United Kingdom
– -$245K -51,016 Closed
Citigroup
48
Citigroup
New York
– -$203K -42,026 Closed
UBS AM
49
UBS AM
Illinois
– -$188K -38,917 Closed
LI
50
Leap Investments
Illinois
– -$187K -38,700 Closed
1
2
3 4

STML Hedge Fund Activity: Q2 2020 in Review

0 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Stemline Therapeutics, Inc. (STML) for Q2 2020, worth a combined $0 — down 100% from $194M a quarter earlier.

Sellers outnumbered buyers: 94 funds closed out of STML and 0 opened new positions — a net loss of 94 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Eventide Asset Management, exiting entirely with an estimated $20.1M sold.

  • 0 institutional investors held Stemline Therapeutics, Inc. (STML) as of Q2 2020, down from 94 in Q1 2020.
  • Funds reported $0 of Stemline Therapeutics, Inc. stock for Q2 2020, down 100% quarter-over-quarter.
  • 0 funds opened new Stemline Therapeutics, Inc. positions in Q2 2020 and 94 closed out, a net change of -94 holders.
  • The largest Stemline Therapeutics, Inc. seller in Q2 2020 was Eventide Asset Management, an estimated $20.1M sold.

Based on aggregated 13F filings for Q2 2020.